These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 130494)
1. Effect of PS-K, a protein polysaccharide, on pulmonary metastases of a C3H mouse squamous cell carcinoma. Usui S; Urano M; Koike S; Kobayashi Y J Natl Cancer Inst; 1976 Jan; 56(1):185-7. PubMed ID: 130494 [TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of protein-bound polysaccharide preparation, PS-K, against 3-methylcholanthrene-induced fibrosarcoma in C57BL/6 mice. Ohno R; Imai K; Yokomaku S; Yamada K Gan; 1975 Dec; 66(6):679-81. PubMed ID: 131730 [TBL] [Abstract][Full Text] [Related]
3. Effect of corynebacterium liquefaciens on a C3Hf mouse squamous cell carcinoma. Ando K; Urano M; Nesumi N; Koike S Cancer Res; 1977 Sep; 37(9):3115-9. PubMed ID: 884666 [TBL] [Abstract][Full Text] [Related]
4. Mouse strain difference in the expression of antitumor activity of PS-K. Yoshikumi C; Nomoto K; Matsunaga K; Fuji T; Takeya K Gan; 1975 Dec; 66(6):649-54. PubMed ID: 131729 [TBL] [Abstract][Full Text] [Related]
5. Immunochemotherapy of transplanted KMT-17 tumor in WKA rats by combination of cyclophosphamide and immunostimulatory protein-bound polysaccharide isolated from basidiomycetes. Akiyama J; Kawamura T; Gotohda E; Yamada Y; Hosokawa M; Kodama T; Kobayashi H Cancer Res; 1977 Sep; 37(9):3042-5. PubMed ID: 884662 [TBL] [Abstract][Full Text] [Related]
6. Diminution of cyclophosphamide-induced suppression of antitumor immunity by an immunomodulator PS-K and combined therapeutic effects of PS-K and cyclophosphamide on transplanted tumor in rats. Mizushima Y; Yuhki N; Hosokawa M; Kobayashi H Cancer Res; 1982 Dec; 42(12):5176-80. PubMed ID: 7139621 [TBL] [Abstract][Full Text] [Related]
7. The therapeutic effects of an immunopotentiator, PS-K, on 3-methylcholanthrene-induced autochthonous tumors in C57BL/6 mice in combination with the surgical removal of primary sites. Hosokawa M; Mizukoshi T; Morikawa K; Xu ZY; Kobayashi H Cancer Immunol Immunother; 1986; 22(3):181-5. PubMed ID: 3731203 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of pulmonary metastasis of Lewis lung carcinoma by a glucan, Schizophyllan. Yamamoto T; Yamashita T; Tsubura E Invasion Metastasis; 1981; 1(1):71-84. PubMed ID: 6234252 [TBL] [Abstract][Full Text] [Related]
9. Treatment with cortisone plus heparin or hexuronyl hexoaminoglycan sulfates of murine tumors and their lung deposits. Milas L; Hunter N; Basic I Clin Exp Metastasis; 1985; 3(4):247-55. PubMed ID: 4075612 [TBL] [Abstract][Full Text] [Related]
10. [Enhancement of irradiation effect in carcinoma of the uterine cervix with the administration of protein-bound polysaccharide kureha (PS-K)]. Kazuta M Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1908-14. PubMed ID: 4056535 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of PS-K and busulfan on the recurrent and metastatic diseases after the surgical removal of 3-methylcholanthrene-induced autochthonous tumors in C57BL/6 mice. Hosokawa M; Mizukoshi T; Sugawara M; Kobayashi H Jpn J Cancer Res; 1985 Jan; 76(1):61-7. PubMed ID: 3918911 [TBL] [Abstract][Full Text] [Related]
12. Spleen peptides (Polyerga) inhibit development of artificial lung metastases of murine mammary carcinoma and increase efficiency of chemotherapy in mice. Zarkovic N; Hartleb M; Zarkovic K; Borovic S; Golubic J; Kalisnik T; Frech S; Klingmüller M; Loncaric I; Bosnjak B; Jurin M; Kuhlmey J Cancer Biother Radiopharm; 1998 Feb; 13(1):25-32. PubMed ID: 10850339 [TBL] [Abstract][Full Text] [Related]
13. Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma. Teicher BA; Williams JI; Takeuchi H; Ara G; Herbst RS; Buxton D Anticancer Res; 1998; 18(4A):2567-73. PubMed ID: 9703911 [TBL] [Abstract][Full Text] [Related]
14. Enhancement by cyclophosphamide of experimental pulmonary metastases formation of Lewis lung carcinoma. I. Dose-dependence and kinetics of cyclophosphamide effect. Strzadała L; Rak J; Kuśnierczyk H Arch Immunol Ther Exp (Warsz); 1985; 33(6):825-9. PubMed ID: 3833119 [TBL] [Abstract][Full Text] [Related]
15. Correlation of differences in antigenicity of four 3-methyl-cholanthrene-induced tumors in syngeneic mice with the susceptibility of tumors to an immunopotentiator, PS-K. Abe S; Yamazaki M; Mizuno D Gan; 1978 Apr; 69(2):223-8. PubMed ID: 680462 [TBL] [Abstract][Full Text] [Related]
16. Survival of mice with metastatic osteosarcoma treated by cyclophosphamide or radiotherapy. Shaeffer J; El-Mahdi AM; Constable WC Cancer Res; 1975 Dec; 35(12):3596-8. PubMed ID: 1059504 [TBL] [Abstract][Full Text] [Related]
17. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors. Nitta K; Tanaka T; Takeuchi M Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657 [TBL] [Abstract][Full Text] [Related]
18. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma. Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446 [TBL] [Abstract][Full Text] [Related]
19. [Effects of PS-K as adjuvant therapy for primary lung cancer--an autopsy case]. Okazaki A; Niibe H; Mitsuhashi N; Ito J; Tatezawa T; Sakaino K; Baba T; Sakata N Gan No Rinsho; 1984 Oct; 30(13):1707-12. PubMed ID: 6513025 [TBL] [Abstract][Full Text] [Related]
20. Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2. Milas L; Hersh EM; Hunter N Cancer Res; 1981 Jun; 41(6):2378-85. PubMed ID: 7237436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]